Skip to content
MMJ Gazette
  Sunday 21 December 2025
  • About
  • Contact Us
  • Privacy Policy
  • Terms and Conditions
  • Authors
  • Home
  • News
  • CBD
  • Cannabis
  • Drugs
  • Marijuana
  • Tobacco
  • Law
Trending
December 20, 2025Trump Signs Order to Reclassify Cannabis, Sparking Industry Shift December 19, 2025New Jersey Bill Allows Hemp THC Drinks in Liquor Stores December 18, 2025PharmaCann Strikes $49M Deal to Sell Colorado Assets to Vireo December 17, 2025Connecticut Cannabis Prices Keep Falling in November December 16, 2025Trump Eyes Major Shift in Cannabis Rules December 10, 2025New York Cannabis Boss Quits Amid Massive Probe Failure December 9, 2025Florida’s Medical Marijuana Patient Growth Slows in 2025 December 6, 2025California and New York Cannabis Brands Battle for Glory: Winners Revealed at First MJBowl December 5, 2025Minnesota Cannabis Market Hits Roadblock with Transporter Shortage December 4, 2025Verano CEO Eyes Big Changes for Weed Business at MJBizCon
MMJ Gazette
MMJ Gazette
  • About
  • Contact Us
  • Privacy Policy
  • Terms and Conditions
  • Authors
MMJ Gazette
  Cannabis  Rubicon Organics Reports Strong Growth in 2023 Annual Report
CannabisNews

Rubicon Organics Reports Strong Growth in 2023 Annual Report

Lars BeckersLars Beckers—March 28, 20240
FacebookTwitterPinterestLinkedInTumblrRedditVKWhatsAppEmail

Rubicon Organics Inc., a leading licensed producer of premium organic cannabis, has released its 2023 Annual Report, showcasing impressive financial results and strategic achievements. The company’s commitment to quality and innovation has solidified its position in the market, making it a force to be reckoned with.

Rubicon

 

Key Highlights from the 2023 Annual Report

1. Revenue Surge and Profitability

  • Net Revenue: Rubicon Organics achieved $40.1 million in net revenue for the twelve months ending December 31, 2023, marking a 13% increase compared to the previous year.
  • Adjusted EBITDA: The company reported $4.4 million in adjusted EBITDA during the same period, demonstrating consistent profitability.
  • Operating Cash Flow: Operating cash flow reached $5.0 million, reflecting the sixth consecutive quarter of positive cash flow.

2. Market Share and Brand Success

  • Premium Flower and Pre-Rolls: Rubicon Organics secured a 6.9% national market share in premium flower and pre-rolls, reinforcing its reputation for high-quality cannabis products.
  • Topical Dominance: The company’s brand, WildflowerTM, emerged as the number one topical brand in Canada, capturing an impressive 21.8% market share.
  • Premium Concentrates: Rubicon Organics claimed a 15.2% national market share in premium concentrates, further validating its market presence.

3. Award-Winning Recognition

  • Rubicon Organics received accolades, including the prestigious “Cannabis Company of the Year” and the “People’s Choice for Best Weed” awards.
  • The company’s commitment to excellence and product quality resonated with consumers and industry experts alike.

4. Product Expansion and Innovation

  • In 2023, Rubicon Organics diversified its product portfolio.
    • Edibles: The company entered the edibles market through a co-manufacturing relationship with 1964 Supply Co., launching Canada’s first single-strain live rosin edibles, which are vegan and gluten-free.
    • Wildflower™ Edibles: Wildflower introduced edibles containing minor cannabinoids (CBN, CBG, and CBD) alongside full-spectrum THC live rosin.
    • Topical Products: Wildflower expanded its offerings with products like the Extra Strength Relief Stick and the 1:1 CBD/THC Relief Stick.

5. Future Initiatives

  • Rubicon Organics plans to enter the vape market by leveraging additional biomass from its contract-grow strategy.
  • The highly anticipated launch of full spectrum extract (FSE) cured resin vapes under 1964 Supply Co. is expected to drive significant growth in 2024.

Conclusion

Rubicon Organics’ 2023 Annual Report underscores its commitment to quality, innovation, and sustainable growth. As the cannabis industry evolves, the company remains poised to lead the way with its premium organic offerings.

FacebookTwitterPinterestLinkedInTumblrRedditVKWhatsAppEmail

Lars Beckers

Lars Beckers is a distinguished senior content writer at MMJ Gazette, bringing a wealth of experience and expertise to the realm of medical marijuana and cannabis-related content. With a deep understanding of the industry and a passion for sharing knowledge, Lars's articles offer readers comprehensive insights and engaging narratives in the dynamic world of cannabis. Known for his meticulous research, clarity of expression, and commitment to delivering high-quality content, Lars brings a seasoned perspective to his work, educating and informing audiences on the latest trends and developments in the field.

A New Leaf in Cannabis Commerce: Kevin Nafte’s Strategic Move to Lyphe Australia
Arizona Cannabis Sales Reach $1.43 Billion in 2023
Related posts
  • Related posts
  • More from author
Cannabis

Trump Signs Order to Reclassify Cannabis, Sparking Industry Shift

December 20, 20250
Cannabis

New Jersey Bill Allows Hemp THC Drinks in Liquor Stores

December 19, 20250
Cannabis

PharmaCann Strikes $49M Deal to Sell Colorado Assets to Vireo

December 18, 20250
Load more
Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

SEARCH
PROMOTIONS
RECENT POSTS
  • Trump Signs Order to Reclassify Cannabis, Sparking Industry Shift
  • New Jersey Bill Allows Hemp THC Drinks in Liquor Stores
  • PharmaCann Strikes $49M Deal to Sell Colorado Assets to Vireo
  • Connecticut Cannabis Prices Keep Falling in November
  • Trump Eyes Major Shift in Cannabis Rules
  • New York Cannabis Boss Quits Amid Massive Probe Failure
  • Florida’s Medical Marijuana Patient Growth Slows in 2025
  • California and New York Cannabis Brands Battle for Glory: Winners Revealed at First MJBowl
  • Minnesota Cannabis Market Hits Roadblock with Transporter Shortage
  • Verano CEO Eyes Big Changes for Weed Business at MJBizCon
    © MMJ Gazette. 2024
    • About
    • Contact Us
    • Privacy Policy
    • Terms and Conditions
    • Authors